Evidence map›Paper›PMID 29437694›Full record

ArticleEMBO reports2018

Mouse GTSF1 is an essential factor for secondary piRNA biogenesis.

Takuji Yoshimura, Toshiaki Watanabe, Satomi Kuramochi-Miyagawa, Noriaki Takemoto, Yusuke Shiromoto, Akihiko Kudo, Masami Kanai-Azuma, Fumi Tashiro, Satsuki Miyazaki, Ami Katanaya and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Abundant piRNA production mediated by theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. PiRNA in Cardiovascular Disease: Focus on Cardiac Remodeling and Cardiac Protection.Journal of cardiovascular translational research · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Developmental roles and molecular mechanisms of Asterix/GTSF1.Wiley interdisciplinary reviews. RNA · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Takuji YoshimuraLaboratory of Reproductive Engineering, The Institute of Experimental Animal Sciences, Osaka University Medical School, Suita, Osaka, Japan.ORCID 0000-0002-7856-0679
Toshiaki WatanabeYale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA.
Satomi Kuramochi-MiyagawaDepartment of Pathology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.ORCID 0000-0003-4396-5868
Noriaki TakemotoDivision of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yusuke ShiromotoDepartment of Pathology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
Akihiko KudoDepartment of Anatomy, Kyorin University School of Medicine Shinkawa, Mitaka, Tokyo, Japan.
Masami Kanai-AzumaCenter for Experimental Animal, Tokyo Medical and Dental University, Bunkyo-ku Tokyo, Japan.
Fumi TashiroDivision of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Satsuki MiyazakiDivision of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Ami KatanayaInstitute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
Shinichiro ChumaInstitute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
Jun-Ichi MiyazakiDivision of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Suita, Osaka, Japan jimiyaza@nutri.med.osaka-u.ac.jp.ORCID 0000-0003-2475-589X
The University of Osaka · JPKyoto University · JPCentral Institute for Experimental Animals · JPKyorin University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The piRNA pathway is a piRNA-guided retrotransposon silencing system which includes processing of retrotransposon transcripts by PIWI-piRNAs in secondary piRNA biogenesis. Although several proteins participate in the piRNA pathway, the ones crucial for the cleavage of target RNAs by PIWI-piRNAs have not been identified. Here, we show that GTSF1, an essential factor for retrotransposon silencing in male germ cells in mice, associates with both MILI and MIWI2, mouse PIWI proteins that function in prospermatogonia. GTSF1 deficiency leads to a severe defect in the production of secondary piRNAs, which are generated from target RNAs of PIWI-piRNAs. Furthermore, in

Indexed as

Gene Expression RegulationTranscription, GeneticAdult Germline Stem CellsAnimalsCell NucleusGene AmplificationGene SilencingGenes, Intracisternal A-ParticleIntracellular Signaling Peptides and ProteinsLong Interspersed Nucleotide ElementsMaleMiceMice, KnockoutModels, BiologicalMultiprotein ComplexesProtein BindingCue110 protein, mouseIntracellular Signaling Peptides and ProteinsMultiprotein ComplexesProteinsRecombinant Fusion ProteinsRetroelementsRNA, Small Interferingping‐pong cyclepiRNAsPIWIsecondary piRNA biogenesistransposon silencing

Identifiers

PMID29437694
PMCPMC5891400
OpenAlexW2785348599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.